Factors Associated with Permanent Pacemaker Placement After Tricuspid Valve Operations
Salman Zaheer,Sari D. Holmes,Emily Rodriguez,Nolan M. Winicki,Emily Larson,Rachael Quinn,Gorav Ailawadi,A. Marc Gillinov,James S. Gammie
DOI: https://doi.org/10.1016/j.athoracsur.2024.09.042
IF: 5.113
2024-10-20
The Annals of Thoracic Surgery
Abstract:BACKGROUND Conduction abnormalities requiring permanent pacemaker (PPM) implantation are common after tricuspid valve operations, though incidence is variable. This study aims to investigate contemporary rates of and risk factors for PPM after tricuspid operations. METHODS The Society of Thoracic Surgeons Adult Cardiac Surgery Database was used to identify patients with tricuspid repair or replacement from 2011 to 2020. Factors independently associated with risk of postoperative PPM during index hospital admission were examined using multivariable logistic regression with a complete case approach. Annualized hospital and surgeon volumes were calculated. RESULTS We identified 71,937 patients undergoing tricuspid operations. Median patient age was 66 (53–74) years, 56% were female ( n =40,590), and median ejection fraction was 56% (48%–60%). Tricuspid operations were concomitant in 87% ( n =62,457), elective in 62% ( n =44,393), and included repair in 86% ( n =61,720). Overall postoperative incidence of PPM was 15% ( n =10,857); 13% ( n =8,304) after repair and 25% ( n =2,553) after replacement; 4% ( n =174) for isolated tricuspid repair and 24% ( n =1,248) for isolated tricuspid replacement. Multivariable analysis showed baseline characteristics, endocarditis, concomitant operations, longer CPB time, tricuspid replacement, and lower hospital and surgeon tricuspid operative volumes were independently associated with greater risk for PPM. After adjustment, tricuspid replacement had 3.2 times greater PPM risk compared to tricuspid repair. CONCLUSIONS Nationally, 15% of patients undergoing tricuspid operations required postoperative PPM implantation. PPM risk was increased with concomitant valve operations, tricuspid replacement, longer CPB time, and operations performed by less experienced surgeons and centers. Innovation is needed to decrease this significant morbidity.
surgery,cardiac & cardiovascular systems,respiratory system